الفهرس 
InttroducttiionOnly 14 pages are availabe for public view
 |  | from | 182 |  |  |
| | | from | 182 | | |
Abstract
Ischemic heart disease was the leading cause of death for both men and women worldwide in 2004. Diabetes mellitus increase the risk for developing coronary heart disease. Most cases of myocardial infarction with ST elevation on ECG (STEMI) are treated with reperfusion therapy, such as percutaneous coronary intervention (PCI) or thrombolysis. Non-ST elevation myocardial infarction (NSTEMI) may be managed with medication, although PCI may be required. Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat the stenotic (narrowed) coronary arteries of the heart found in coronary heart disease. These stenotic segments are due to the build up of the cholesterol-laden plaques that form due to atherosclerosis. Coronary artery bypass graft surgery is a surgical procedure performed to relieve angina and reduce the risk of death from coronary artery disease. Strategies to Improve Outcomes in Diabetic Patients Undergoing Coronary Revascularization: CABG: If possible, use 1 arterial conduit, preferably an IMA, with preference given to anastomoses to the LAD artery. Maintain rigid perioperative glycemic control (serum glucose 180 mg/dL) with a continuous insulin infusion. PCI: DES, with either SES or PES, are strongly recommended. Gp IIb/IIIa inhibitors are strongly recommended, especially during an ACS.